Mechanism: Aligning alternate-day fasting to the early active circadian phase boosts NAD+ and SIRT1, enhancing PGC-1α and PPARα signaling for robust ketone production. Readout: Readout: Aligned fasting shows higher β-hydroxybutyrate, increased SIRT1-PGC-1α acetylation, and improved metabolic flexibility compared to misaligned fasting.
Hypothesis
Aligning the feeding window of alternate-day fasting (ADF) to the early active phase of the circadian rhythm enhances SIRT1‑PGC‑1α and PPARα signaling, producing higher ketone levels and greater metabolic flexibility than the same ADF protocol with a misaligned feeding window.
Mechanistic Rationale
SIRT1 activity depends on NAD⁺, which oscillates with a circadian peak during the early active phase in humans[8]. When fasting coincides with this NAD⁺ peak, SIRT1 deacetylates PGC‑1α more effectively, upregulating hepatic gluconeogenic and fatty‑oxidation genes (MCAD, CPT‑1a)[2] and amplifying PPARα‑driven mitochondrial ketogenesis in muscle[3]. Conversely, fasting during the rest phase lowers NAD⁺ availability, blunting SIRT1 despite identical caloric restriction, leading to weaker ketone production and persistent glucose reliance[7]. This mechanistic mismatch can explain why elevated fasting ketones predict incident type 2 diabetes in some cohorts[5]—they may reflect a maladaptive, mistimed metabolic response rather than beneficial flexibility.
Testable Predictions
- Participants undergoing ADF with meals consumed between 07:00‑13:00 (aligned) will achieve higher β‑hydroxybutyrate concentrations during fasting periods than those eating between 13:00‑19:00 (misaligned), despite identical caloric intake.
- The aligned group will show a greater increase in the SIRT1‑PGC‑1α acetylation ratio in peripheral blood mononuclear cells and a larger rise in PPARα target gene expression (e.g., CPT‑1a, ACOX1) after three weeks.
- Metabolic flexibility, assessed by the decline in respiratory quotient during a 24‑h fast, will improve significantly only in the aligned ADF arm.
- Changes in fasting insulin and HOMA‑IR will correlate positively with ketone AUC only in the aligned condition, resolving the paradox of ketone‑T2D association.
Experimental Design
A randomized, crossover trial in 40 overweight, insulin‑sensitive adults. Each participant completes two 3‑week ADF periods separated by a 4‑week washout. In one period, all food is ingested within a 6‑hour window starting at 07:00; in the other, the same caloric load is consumed within a 6‑hour window starting at 13:00. Continuous subcutaneous ketone and glucose monitors record 24‑h profiles[6]. At baseline and end of each period, blood samples are taken for SIRT1 activity, PGC‑1α acetylation, PPARα target mRNA, and standard metabolic indices. Indirect calorimetry measures respiratory quotient across fed and fasted states. Primary outcome: difference in fasting β‑hydroxybutyrate AUC between aligned and misaligned ADF. Secondary outcomes: changes in metabolic flexibility, insulin sensitivity, and gene‑expression signatures.
If the aligned ADF fails to produce superior ketone elevations, SIRT1 activation, or metabolic flexibility improvements, the hypothesis is falsified. Conversely, confirmation would support a circadian‑gated mechanism for optimizing intermittent fasting protocols and inform personalized ketone targets based on timing rather than absolute concentration.
Comments
Sign in to comment.